Wendy West Feinstein

Most recently, Wendy served as lead trial counsel for Teva Pharmaceuticals and affiliated entities, achieving the first trial defense win in the national opioid litigation. The trial victory came after seven years of litigation and over four months of trial in Orange County, California Superior Court. Wendy and a Morgan Lewis team developed and implemented an aggressive trial defense strategy, obtaining key testimony from plaintiffs and defense witnesses and effectively arguing legal and evidentiary issues. The trial began during the global pandemic and was held entirely by Zoom, highlighting Wendy’s flexibility, creativity, and ability to lead a team and successfully try a large, complicated case under any circumstances and format.

With experience in multiple jurisdictions, Wendy works with clients to engage in early assessment of disputes including determining whether the client is a primary liability target, whether the disputed issue is inextricably tied to the client’s brand or core business, and whether regulatory or other action is related to the dispute, among other things. She closely partners with her clients’ legal and business teams to devise efficient and cost-effective strategies to manage litigation at every stage of the dispute, from prelitigation negotiations, evaluating options for early motion practice, and assessing pros and cons of consolidated or coordinated actions to dispositive motion practice, selecting and challenging experts, jury selection, and trial strategy. Wendy guides clients through litigation and trial while minimizing exposure and containing costs to achieve favorable outcomes that align with the client’s business objectives and risk tolerance.

A trusted advisor and collaborator in large-scale pharmaceutical litigation, Wendy currently serves with other Morgan Lewis lawyers as national coordinating and trial counsel for opioid manufacturers in federal multidistrict litigation (MDL) and state opioid litigation, as well as in federal MDL generics pricing litigation. She has also served as trial counsel in False Claims Act cases and serves and has served as a key national defense team leader in several other MDL and state-coordinated litigations such as In re: Philips Recalled CPAP, Bi-Level PAP, and Mechanical Ventilator Products Liability Litigation; In re: Generic Pharmaceuticals Pricing Antitrust Litigation; In re National Prescription Opiate Litigation, In re Xarelto (Rivaroxiban) Products Liability Litigation; In re: Mirena IUD Products Liability Litigation; and In re: Yasmin and YAZ (Drospirenone) Marketing, Sales Practices and Products Liability Litigation, and related state coordinated proceedings.

In medical device matters, Wendy’s pretrial strategy and cross-examination of experts have resulted in the exclusion of opposing experts and dismissal of claims through summary judgment. She has also successfully achieved early dismissals of medical device cases on motions to dismiss or early negotiations to resolve matters without protracted litigation. Where matters have gone to verdict, Wendy has achieved a consistently positive track record of success. Her trial experience spans many industries including manufacturing, private equity, and construction, and includes jury and bench trials, arbitrations, injunctions, and Markman hearings throughout the United States.

Wendy is an active member of the International Association of Defense Counsel, Q. Todd Dickinson IP Inn of Court, Allegheny County Bar Association Federal Court Section Council, and Federal Bar Association. She frequently speaks at conferences and CLE events about pharmaceutical and False Claims Act litigation. Wendy also serves on the Investigative Division of the Pennsylvania Bar Association Judicial Evaluation Commission and on a Merit Panel for the US District Court for the Western District of Pennsylvania. She has also served on nonprofit boards.

Wendy currently serves as the managing partner of the firm’s Pittsburgh office.